Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Remain Cool and Solid: Top Summer Food sources for 2024 - 2Unraveling the Specialty of Picking Your Ideal Travel Objective
- 3Meet ‘NASA Mike,’ who’s done 105,000 handstands around the world
- 4Remain Fit and Sound with These Exercise Fundamentals
- 5Tech Patterns 2023: 12 Advancements to Keep an eye Out For
- Avoid Large Crowds In Bali & Swim At This Peaceful Waterfall With A Gorgeous, Natural Pool
- Reclassifying Achievement: Individual Accounts of Seeking after Interests
- She loves to give experiences. He goes for sentimental gifts. They ask an expert: What is the perfect holiday present?
- Extravagance SUVs for Seniors: Solace, Innovation, and Security
- James Webb Space Telescope spies mysterious high-energy radiation in star nursery
- Turning into a Sharp Financial backer: Individual budget Wins
- Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaks
- Anthony Joshua's driver charged over Nigeria crash that killed two
- US students studying housing, health outcomes and sustainability win 2026 Rhodes scholarships
